These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2962087)

  • 1. [Preventive systemic antibiotherapy with ceftriaxone alone in neutropenic patients treated in a protected environment].
    Harousseau JL; Milpied N; Reynaud AE; Derriennic M; Bourhis JH; Courtieu AL
    Presse Med; 1987 Oct; 16(35):1737-40. PubMed ID: 2962087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prophylactic systemic antibiotherapy with only ceftriaxone in neutropenic patients treated in a protected environment].
    Harousseau JL; Milpied N; Reynaud AE; Derriennic M; Bourhis JH; Courtieu AL
    Pathol Biol (Paris); 1988 Sep; 36(7):907-11. PubMed ID: 3059275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy of prophylactic intravenous antibiotherapy with ceftriaxone in post-chemotherapy agranulocytic patients.
    Pignon B; Thiriet L; Aubert D; Pennaforte JL; Vilque JP; Lartigue B; Jolly D; Bajolet-Laudinat O; Etienne JC
    Nouv Rev Fr Hematol (1978); 1990; 32(4):249-52. PubMed ID: 2290711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone vs. azlocillin and netilmicin in the treatment of febrile neutropenic children.
    Smith L; Will AM; Williams RF; Stevens RF
    J Infect; 1990 May; 20(3):201-6. PubMed ID: 2187928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ceftazidime for the treatment of infections in neutropenic children].
    Leverger G; Arlet G; Bancillon A; Schaison G
    Presse Med; 1988 Oct; 17(37):1974-6. PubMed ID: 2973600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
    Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Piperacillin combined with netilmicin and cloxacillin. Usefulness in the treatment of febrile episodes in neutropenic children].
    Schaison G; Leverger G; Arlet G
    Presse Med; 1986 Dec; 15(46):2345-6. PubMed ID: 2949283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone plus amikacin in neutropenic patients: a report on 100 cases.
    Blanc C; Pollet JP; Bauters F
    Chemotherapy; 1991; 37(5):382-8. PubMed ID: 1804600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
    J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis, cost and effectiveness of therapy of infections caused by gram-positive organisms in neutropenic children.
    Schaison GS; Decroly FC
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():61-7. PubMed ID: 1829078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
    Gupta A; Swaroop C; Agarwala S; Pandey RM; Bakhshi S
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):635-41. PubMed ID: 19684522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation.
    Schmeiser T; Kurrle E; Arnold R; Krieger D; Heit W; Heimpel H
    Infection; 1988; 16(1):19-24. PubMed ID: 3283035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empirical antimicrobial therapy in the neutropenic host.
    Young LS
    N Engl J Med; 1986 Aug; 315(9):580-1. PubMed ID: 3526156
    [No Abstract]   [Full Text] [Related]  

  • 16. Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation.
    Menichetti F; Felicini R; Bucaneve G; Aversa F; Greco M; Pasquarella C; Moretti MV; Del Favero A; Martelli MF
    Bone Marrow Transplant; 1989 Sep; 4(5):489-92. PubMed ID: 2790326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
    Marie JP; Pico JL; Chiche D; Fitoussi F; Delmer A; Baume D; Rio B; Ajchenbaum F; Richet H; Tancrède C
    Presse Med; 1988 Oct; 17(37):1968-70. PubMed ID: 2973598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of teicoplanin in neutropenic patients: values and limits].
    Espinouse D; Chomarat M
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):552-6. PubMed ID: 2143573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative randomized study of protected environment plus oral antibiotics versus oral antibiotics alone in neutropenic patients.
    Lohner D; Debusscher L; Prévost JM; Klastersky J
    Cancer Treat Rep; 1979 Mar; 63(3):363-8. PubMed ID: 106963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.